Nara Organics recalled all lots of its whole-milk powdered infant formula currently on the market after FDA and CDC identified three infant botulism cases in California, Washington and Pennsylvania. No deaths were reported in the company notice.
Key facts
- Recall scope: all currently marketed lots
- Package sizes: 700 g and 400 g
- Three hospitalized cases were reported in the notice
- No deaths were reported
Timeline
July 2025 to June 2026 — The recalled formula was distributed nationally. June 13, 2026 — The all-lot recall notice was published. The investigation and official updates continue through FDA channels.
Infant botulism is a serious medical condition. The FDA notice also draws an essential evidence boundary: the product had not tested positive for Clostridium botulinum at the time of publication, even though the epidemiological link prompted an all-lot recall.
The recall covers all currently marketed lots of the named Nara formula, not infant formula as a category. Retailers and families should follow the official product identifiers rather than general social-media lists.
What happened?
The June 13 recall covers 700-gram and 400-gram cans distributed nationally through Target stores, Target.com and Nara’s website from July 2025 through June 2026. The notice says the three infants were hospitalized and had consumed the product.
Why it matters
Infant botulism is a serious medical condition. The FDA notice also draws an essential evidence boundary: the product had not tested positive for Clostridium botulinum at the time of publication, even though the epidemiological link prompted an all-lot recall.
Background
Nara Organics recalled all lots of its whole-milk powdered infant formula currently on the market after FDA and CDC identified three infant botulism cases in California, Washington and Pennsylvania. No deaths were reported in the company notice.
What each side says
FDA and CDC notified the company about three cases with reported product exposure. Nara’s notice states that no product had tested positive at publication. Both points belong in the same account.
What happens next
FDA’s recall page and linked outbreak information are the authoritative places for updates. Families with the product should follow the agency’s instructions and use the UPC and package size to identify it.
Nivegu analysis
The responsible reading separates three facts: cases were reported, exposure was identified, and laboratory confirmation in the formula had not occurred when the notice was published. The recall is a safety action under uncertainty, not permission to erase that uncertainty.
Different viewpoints
A broad recall reduces the chance that families must interpret incomplete lot information while the investigation continues. Clear product sizes and UPCs help identify the covered formula.
Families relying on the product face immediate disruption, and infants are the population at risk. The company’s notice directs consumers to stop using the recalled formula and seek medical care if symptoms are present.
What we know
The central claims in this briefing are tied to the sources below. Analysis and inference are labeled separately; uncertainty stays visible.
✓ SOURCE-BACKEDWhat are you still wondering?
Answers will use this briefing and its cited sources.Sources
Read the evidence, not just our conclusion.
01FDA — Nara infant formula recall↗02CDC — About botulism↗Questions, answered.
What is the short version?
Nara Organics recalled all lots of its whole-milk powdered infant formula currently on the market after FDA and CDC identified three infant botulism cases in California, Washington and Pennsylvania. No deaths were reported in the company notice.
Why does this matter now?
Infant botulism is a serious medical condition. The FDA notice also draws an essential evidence boundary: the product had not tested positive for Clostridium botulinum at the time of publication, even though the epidemiological link prompted an all-lot recall.
What should readers watch next?
The recall covers all currently marketed lots of the named Nara formula, not infant formula as a category. Retailers and families should follow the official product identifiers rather than general social-media lists.
Corrections & updates
This briefing was published 8/4/2026 and last updated 8/4/2026. Material corrections and revisions are recorded visibly.
Request a correction
